Skip to main content
SpringerLink
Log in

New hope for systemic sclerosis patients with digital ulcers

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wigley FM, Seibold JR, Wise RA, et al.: Intravenous iloprost treatment of Raynaud’s phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 1992, 19:1407–1414.

    PubMed  CAS  Google Scholar 

  2. Badesch DB, Tapson VF, McGoon MD, et al.: Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000, 132:425–434.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. John Varga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varga, J. New hope for systemic sclerosis patients with digital ulcers. Curr Rheumatol Rep 7, 127–128 (2005). https://doi.org/10.1007/s11926-005-0064-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-005-0064-1

Keywords

Search

Navigation